Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 SEK | -2.78% | -13.37% | -43.73% |
Apr. 25 | AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR). | CI |
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Martin Jönsson
CEO | Chief Executive Officer | 56 | 20-01-07 |
Johan Sandin
FOU | Founder | 54 | 16-11-21 |
Birgitta Lundvik
DFI | Director of Finance/CFO | 57 | 16-12-31 |
Märta Segerdahl
CTO | Chief Tech/Sci/R&D Officer | 68 | 21-03-31 |
Mikael Widell
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 16-12-31 | |
Ragnar Linder
BRD | Director/Board Member | 71 | 16-12-31 |
Ellen Donnelly
BRD | Director/Board Member | 50 | 17-12-31 |
Eva Lilienberg
BRD | Director/Board Member | 68 | 20-12-31 |
Director/Board Member | 57 | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 93,130,518 | 64,659,961 ( 69.43 %) | 0 | 69.43 % |
Company contact information
Sector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.73% | 10.06M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- ALZCUR Stock
- Company AlzeCure Pharma AB